Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
Scientific poster · September 12, 2026

Retigabine tests bioelectric reprogramming control

Download PDFDownload PNG
Full scientific poster: Retigabine tests bioelectric reprogramming control

Full text

This proposed experiment asks whether changing the electrical state of human connective-tissue cells can help them reset their identity even when their nuclei are stiff. Researchers will sort 50 clones, cells descended from one starting cell, into groups defined by soft or stiff nuclei and predicted resetting fate. They will compare retigabine with a solvent-only control, confirm the change in membrane potential, the voltage across a cell membrane, then induce three identity-resetting factors. On day 14, fluorescence sorting will count cells with NANOG-GFP, a green signal of resetting. A benefit in predicted-lock clones across both stiffness groups, with an interaction below p<0.05, would support an electrical control point. Benefit limited to soft nuclei would instead link the effect to mechanical context.

Source article

  1. Can retigabine improve cell resetting independently of nuclear stiffness? Eternal Search · Omega Point. 2026